Evidence map›Paper›PMID 34572779›Full record

ArticleCancers2021

Metallothionein 2A Expression in Cancer-Associated Fibroblasts and Cancer Cells Promotes Esophageal Squamous Cell Carcinoma Progression.

Masaki Shimizu, Yu-Ichiro Koma, Hiroki Sakamoto, Shuichi Tsukamoto, Yu Kitamura, Satoshi Urakami, Kohei Tanigawa, Takayuki Kodama, Nobuhide Higashino, Mari Nishio and 3 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Influence of CCancers · 2023
    Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Masaki ShimizuDivision of Pathology, Department of Pathology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
Yu-Ichiro KomaDivision of Pathology, Department of Pathology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
Hiroki SakamotoDivision of Pathology, Department of Pathology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
Shuichi TsukamotoDivision of Pathology, Department of Pathology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
Yu KitamuraDivision of Pathology, Department of Pathology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
Satoshi UrakamiDivision of Pathology, Department of Pathology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
Kohei TanigawaDivision of Pathology, Department of Pathology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
Takayuki KodamaDivision of Pathology, Department of Pathology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
Nobuhide HigashinoDivision of Pathology, Department of Pathology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
Mari NishioDivision of Pathology, Department of Pathology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.ORCID 0000-0002-7413-0751
Manabu ShigeokaDivision of Pathology, Department of Pathology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
Yoshihiro KakejiDivision of Gastro-intestinal Surgery, Department of Surgery, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.ORCID 0000-0002-2727-0241
Hiroshi YokozakiDivision of Pathology, Department of Pathology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.ORCID 0000-0001-5276-3331
Kobe University · JP

Funding

Japan Society for the Promotion of Science 18K07015Japan Society for the Promotion of Science 20K07373
6 · The paper itself

Abstract

Esophageal cancer has the sixth highest mortality rate worldwide. Cancer-associated fibroblasts (CAFs) are involved in the progression of various cancers. Previously, we demonstrated an association between high expression of the CAF marker, fibroblast activation protein, and poor prognosis of esophageal squamous cell carcinoma (ESCC). We also established CAF-like cells by indirect co-culture of bone marrow-derived mesenchymal stem cells with ESCC cell lines and found metallothionein 2A (MT2A) to be highly expressed in them. Here, to explore the function of MT2A in CAFs, we silenced

Indexed as

cancer-associated fibroblastsesophageal squamous cell carcinomaIGFBP2MT2A

Identifiers

PMID34572779
PMCPMC8464741
OpenAlexW3201597443

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.